Risk of a second breast cancer can be better quantified in women carrying a BRCA mutation
(ECCO-the European CanCer Organisation) The risk of a second breast cancer in patients with high-risk BRCA gene mutations can be more precisely predicted by testing for several other genetic variants, each of which are known to have a small impact on breast cancer risk. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 20, 2018 Category: Cancer & Oncology Source Type: news

Women with DCIS at lowest risk of recurrence if they are post-menopausal or ER+
(ECCO-the European CanCer Organisation) Patients with an early form of breast cancer are less likely to suffer a recurrence if they are post-menopausal or if their tumour is oestrogen receptor positive, according to research presented at the 11th European Breast Cancer Conference. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 20, 2018 Category: Cancer & Oncology Source Type: news

Cannabis oil: Meet the woman taking it for breast cancer recovery
Nikki Bednall says she takes cannabis oil through "desperation not recreation" after her breast cancer. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - March 20, 2018 Category: Consumer Health News Source Type: news

Carboplatin in Neoadjuvant Chemo May Be Helpful in Triple-negative Breast Cancer Carboplatin in Neoadjuvant Chemo May Be Helpful in Triple-negative Breast Cancer
Carboplatin should be considered as a potential component of neoadjuvant chemotherapy for women with high-risk, triple-negative breast cancer, regardless of BRCA status, researchers suggest.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 19, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

How California can break down barriers to breast cancer treatment
More than 29,000 women in California will be diagnosed with breast cancer in 2018. Many of them — especially low-income women, who suffer the worst survival rates — will face economic, emotional and structural obstacles to getting treatment and follow-up care.“Breast cancer is one of the most common diseases, so why is it still so hard for women to get adequate care?” asked Ninez Ponce, associate director of theUCLA Center for Health Policy Research and co-author of atwo-year study of breast cancer barriers in California.  “Women who face the hardship of illness should not also have ...
Source: UCLA Newsroom: Health Sciences - March 19, 2018 Category: Universities & Medical Training Source Type: news

Opinion: No, FDA Didnt Really Approve 23andMes BRCA Test
Rather, the breast cancer mutation screen was classified as a type of medical device with obligations for the company to reduce risks to customers. (Source: The Scientist)
Source: The Scientist - March 19, 2018 Category: Science Tags: News & Opinion,Opinion Source Type: news

Medical News Today: Breast cancer: Obesity may hinder some treatments
Obesity, which is linked to lower survival in many cancers, may be why drugs that inhibit growth of blood vessels that feed cancer don't work, says study. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 19, 2018 Category: Consumer Health News Tags: Obesity / Weight Loss / Fitness Source Type: news

Going beyond social support: fear of receiving compassion from others predicts depression symptoms in breast cancer patients - Trindade IA, Ferreira C, Borrego M, Ponte A, Carvalho C, Pinto-Gouveia J.
BACKGROUND: Recent studies have highlighted the importance of being able to receive compassion and affiliative signals from others. The main aim of the present study was to explore whether social support and fear of receiving compassion from others are pre... (Source: SafetyLit)
Source: SafetyLit - March 19, 2018 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

The use of immunotherapy to treat metastatic breast cancer
(Bentham Science Publishers) The Authors review immunotherapy attempts to treat metastatic breast cancer. They include a) the addition of cytokines to endocrine therapy, b) monoclonal antibodies associated to chemotherapy and c) vaccination. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 19, 2018 Category: Cancer & Oncology Source Type: news

Why are women at high breast cancer risk not having supplemental MRI screening?
(Mary Ann Liebert, Inc./Genetic Engineering News) Women at high lifetime breast cancer risk might benefit from breast MRI screening in addition to routine mammography, but a new study shows that breast MRI is greatly underutilized even though access is widely available. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 19, 2018 Category: Cancer & Oncology Source Type: news

HRD-positive breast cancer patients fare better with adjuvant AC chemotherapy
(SWOG) People with tough-to-treat triple negative breast cancer, whose tumors also don't allow for double-strand DNA repair, fare better when treated with a common adjuvant breast cancer chemotherapy combination, according to results from a SWOG clinical trial. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 19, 2018 Category: International Medicine & Public Health Source Type: news

In BRCA mutation carriers, obesity is linked with increased DNA damage
(The Endocrine Society) Being obese or having a higher body mass index (BMI) while carrying a BRCA (BReast CAncer gene) mutation is positively linked with higher levels of damage to the DNA in normal breast gland cells, new research suggests. The results of the study will be presented Sunday, March 18, at ENDO 2018, the 100th annual meeting of the Endocrine Society in Chicago, Ill. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 18, 2018 Category: International Medicine & Public Health Source Type: news

TCM medicines confirmed to accelerate cell death of breast cancer tumors
(Natural News) A team of researchers from the Beijing University of Chinese Medicine has uncovered promising breast cancer treatment in two unlikely substances. One is tetrandrine, a natural plant-based alkaloid with health benefits ranging from pain alleviation to tumor growth inhibition, while the other is arsenic trioxide, a traditional Chinese remedy with a history of... (Source: NaturalNews.com)
Source: NaturalNews.com - March 17, 2018 Category: Consumer Health News Source Type: news

Abortions in the U.S. Are Safe and Effective, a New Report Says
The majority of legal abortions performed in the U.S. are safe, free of complications and devoid of long-term health effects, according to a comprehensive new report. A committee assembled by the National Academies of Sciences, Engineering, and Medicine analyzed available data on abortion safety, quality and care. The resulting report, published Friday, says the four major abortion methods used in the U.S. — medication, aspiration, induction and dilation and evacuation (D&E) — are all safe and effective, and that complications are rare. The vast majority of U.S. abortions — 90% — are also perfor...
Source: TIME: Health - March 16, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime Reproductive Health Source Type: news

' You Don't Always Need to Do More': De-escalating Breast Cancer Therapy'You Don't Always Need to Do More': De-escalating Breast Cancer Therapy
Patients diagnosed with breast cancer could soon be benefiting from what could be described as the next step in personalized therapy: de-escalation of treatment to minimize adverse effects.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 16, 2018 Category: Consumer Health News Tags: Hematology-Oncology Article Source Type: news

Mayo Clinic's Clinical Trial Matching Project Sees Higher Enrollment in Breast Cancer Trials through Use of Artificial Intelligence
Mayo Clinic and IBM Watson Health (NYSE: IBM) have unveiled results from early use of the Watson for Clinical Trial Matching, an IBM cognitive computing system. Use of this system in the Mayo Clinic oncology practice has been associated with more patients enrolled in Mayo’s breast cancer clinical trials. (Source: eHealth News EU)
Source: eHealth News EU - March 16, 2018 Category: Information Technology Tags: Featured IBM Healthcare Business and Industry Source Type: news

Is artificial intelligence ethical in healthcare?
Artificial intelligence technology holds much promise for improving the quality...Read more on AuntMinnie.comRelated Reading: Deep learning may produce sharp reductions in DBT dose AI can help distinguish lung nodules on CT scans AI, radiomics help distinguish lung nodules on CT scans AI can spot large pneumothoraces on chest x-ray Artificial intelligence shows promise for breast cancer metastases (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 16, 2018 Category: Radiology Source Type: news

Management of Early-Stage HER2-Positive Breast Cancer
During the 2018 Miami Breast Cancer Conference, Dr. Sara Hurvitz discussed current management options for patients with early-stage HER2-positive breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - March 15, 2018 Category: Cancer & Oncology Authors: Sara Hurvitz, MD Tags: Conferences/MBCC News Source Type: news

Hidden Cancers Uncovered With Glowing Dyes
PHILADELPHIA (AP) — It was an ordinary surgery to remove a tumor — until doctors turned off the lights and the patient’s chest started to glow. A spot over his heart shined purplish pink. Another shimmered in a lung. They were hidden cancers revealed by fluorescent dye, an advance that soon may transform how hundreds of thousands of operations are done each year. Surgery has long been the best way to cure cancer. If the disease recurs, it’s usually because stray tumor cells were left behind or others lurked undetected. Yet there’s no good way for surgeons to tell what is cancer and what is not...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 15, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Cancer Dr. Mallika Marshall Local TV TumorGlow Source Type: news

Women in US Territories Get Lower Quality Breast Cancer Care Women in US Territories Get Lower Quality Breast Cancer Care
Older women with breast cancer who live in United States territories are less likely than their peers in the continental U.S. to receive recommended care, a study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 15, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Scientists Discover New Drugs To Treat Hot Flashes
BOSTON (CBS) — Scientists at Imperial College London have developed a new class of experimental drugs to treat menopausal hot flashes. In a clinical trial involving 37 women, the compound called MLE4901 reduced the number of hot flashes by almost three-quarters and significantly reduced the severity. The drug blocks a chemical in the brain called neurokinin B and in the study the drug also improved sleep and concentration during the 4-week study period. MLE4901 can affect liver function but two similar drugs which don’t have this side effect are being studied in larger patient trials including one in the U.S. t...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 14, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Healthwatch Local News Seen On WBZ-TV Syndicated Local Dr. Mallika Marshall Menopause Women's Health Source Type: news

Breast cancer patients in U.S. territories receive lower quality care
(Reuters Health) - Older women with breast cancer who live in United States territories are less likely than their peers in the continental U.S. to receive recommended care, a study suggests. (Source: Reuters: Health)
Source: Reuters: Health - March 14, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Too Few Early Breast CA Patients Given Formal Genetic Counseling
43.5 % of women with early - stage breast cancer with indications for risk evaluation get counseling (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 14, 2018 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pathology, Journal, Source Type: news

Many Breast Cancer Patients Not Receiving Genetic Evaluation Many Breast Cancer Patients Not Receiving Genetic Evaluation
Many breast cancer patients who may benefit from a genetic evaluation are not receiving testing or counseling.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 14, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Mammography finds more cancers in younger women
Compared with mammography screening in women 50 and older, adding screening...Read more on AuntMinnie.comRelated Reading: What are the risks of risk-based breast cancer screening? SABCS: Biannual breast MRI best for young women at high risk DBT in younger women mitigates mammography's 'harms' Groups hail study of breast screening in 40s 'Inexplicably,' doctors support breast screening at 40 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 14, 2018 Category: Radiology Source Type: news

Obesity may promote resistance to antiangiogenic therapy for breast cancer
(Massachusetts General Hospital) A research team led by Massachusetts General Hospital investigators has found, for the first time, that obesity and obesity-related molecular factors appear to induce resistance to antiangiogenic therapy in breast cancer patients and in mouse models of the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 14, 2018 Category: Cancer & Oncology Source Type: news

EDC4: New gene involved in familial breast cancer
(Universitat Autonoma de Barcelona) An international research consortium led by Dr Jordi Surrall é s, director of the Genetics Service at the Hospital de Sant Pau and professor of Genetics at the UAB, and by Dr Miquel À ngel Pujana, director of the ProCURE Research Programme of the Catalan Institute of Oncology (ICO, IDIBELL), has identified a novel gene involved in this type of cancer, known as EDC4. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 14, 2018 Category: International Medicine & Public Health Source Type: news

Area surrounding a tumor impacts how breast cancer cells grow
(Oregon Health& Science University) A research team from Oregon Health& Science University, led by Joe Gray, Ph.D. and Jim Korkola, Ph.D. discover a tumor's 'microenvironment' plays a critical role in how HER2 positive breast cancer responds to treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 14, 2018 Category: International Medicine & Public Health Source Type: news

Ambry Genetics Launches AmbryScore to Assist Health Care Providers in...
New precision genetics risk tool helps clinicians better predict breast cancer risk(PRWeb March 14, 2018)Read the full story at http://www.prweb.com/releases/2018/03/prweb15315664.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 14, 2018 Category: Pharmaceuticals Source Type: news

Genetic Testing Underused in Breast Cancer Patients: Study
(Source: Cancercompass News: Breast Cancer)
Source: Cancercompass News: Breast Cancer - March 14, 2018 Category: Cancer & Oncology Source Type: news

Age-based Breast Cancer Screening Guidelines Ignore Race/Ethnicity Age-based Breast Cancer Screening Guidelines Ignore Race/Ethnicity
Age-based breast cancer screening guidelines that do not account for race may harm nonwhite populations, so lowering the screening age for these individuals should be considered, researchers in Boston say.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 13, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Exploring Current Research on Immunotherapy for Breast Cancer
During the 2018 Miami Breast Cancer Conference, Dr. Elizabeth A. Mittendorf discussed immunotherapy concepts and strategies related to breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - March 13, 2018 Category: Cancer & Oncology Authors: Elizabeth A. Mittendorf, MD, PhD Tags: Breast Cancer Conferences/MBCC News Source Type: news

Lisinopril and Carvedilol Reduce Cardiotoxicity in HER2+ Breast Cancer
Lisinopril and carvedilol reduced cardiotoxicity in patients with HER2-positive breast cancer treated with trastuzumab and anthracyclines. (Source: CancerNetwork)
Source: CancerNetwork - March 13, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Breast Cancer HER2-Positive Breast Cancer News Source Type: news

Optimal Duration of Endocrine Therapy for Breast Cancer Optimal Duration of Endocrine Therapy for Breast Cancer
According to a new study, five years of extended adjuvant letrozole for early breast cancer was not superior to 2.5 years.Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 13, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Genetic Testing Underused in Breast Cancer Cases
The study included just over 1,700 women with early stage breast cancer who could benefit from genetic testing. (Source: WebMD Health)
Source: WebMD Health - March 13, 2018 Category: Consumer Health News Source Type: news

Breast cancer cure hope: Scientists discover genes linked to risks of developing cancer
SCIENTISTS have linked more than 100 genes to an increased risk of breast cancer – paving the way for more personalised treatments, a study has said. A team at The Institute of Cancer Research in London identified a "treasure trove" of specific genes involved in raising a woman's risk of developing the condition. (Source: Daily Express - Health)
Source: Daily Express - Health - March 13, 2018 Category: Consumer Health News Source Type: news

Genetic Testing Underused in Breast Cancer Patients: Study
TUESDAY, March 13, 2018 -- Nearly half of newly diagnosed breast cancer patients who should have genetic testing don't receive it, a new study finds. Genetic testing can play an important part in deciding the best course of treatment, the University... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 13, 2018 Category: General Medicine Source Type: news

Cutting Chemo Heart Risks for Breast Cancer Patients
Title: Cutting Chemo Heart Risks for Breast Cancer PatientsCategory: Health NewsCreated: 3/12/2018 12:00:00 AMLast Editorial Review: 3/13/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - March 13, 2018 Category: Cancer & Oncology Source Type: news

Genetic Testing Underused in Breast Cancer Patients: Study
Title: Genetic Testing Underused in Breast Cancer Patients: StudyCategory: Health NewsCreated: 3/13/2018 12:00:00 AMLast Editorial Review: 3/13/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - March 13, 2018 Category: Cancer & Oncology Source Type: news

Cardiac Agents May Protect Heart from Breast Cancer Tx
(MedPage Today) -- Two studies support possible prophylactic benefits of beta-blocker, ACE inhibitor (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - March 13, 2018 Category: Cardiology Source Type: news

Skp2-dependent reactivation of AKT drives resistance to PI3K inhibitors
The PI3K-AKT kinase signaling pathway is frequently deregulated in human cancers, particularly breast cancer, where amplification and somatic mutations of PIK3CA occur with high frequency in patients. Numerous small-molecule inhibitors targeting both PI3K and AKT are under clinical evaluation, but dose-limiting toxicities and the emergence of resistance limit therapeutic efficacy. Various resistance mechanisms to PI3K inhibitors have been identified, including de novo mutations, feedback activation of AKT, or cross-talk pathways. We found a previously unknown resistance mechanism to PI3K pathway inhibition that results in ...
Source: Signal Transduction Knowledge Environment - March 13, 2018 Category: Science Authors: Clement, E., Inuzuka, H., Nihira, N. T., Wei, W., Toker, A. Tags: STKE Research Articles Source Type: news

Racial Variation in Median Age of Female Breast Cancer Diagnosis
More black, Hispanic, Asian patients diagnosed at younger than 50 years than white patients (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 13, 2018 Category: Cancer & Oncology Tags: Gynecology, Internal Medicine, Oncology, Radiology, Surgery, Journal, Source Type: news

Dogs that could stop men dying by sniffing out prostate cancer
Prostate cancer now kills more men than breast cancer does women - but there's a huge gender health gap. Here, medical detection dogs could prove a game-changer for all involved. (Source: the Mail online | Health)
Source: the Mail online | Health - March 12, 2018 Category: Consumer Health News Source Type: news

ASTRO releases new breast radiation therapy guideline
The American Society for Radiation Oncology (ASTRO) has issued a new clinical...Read more on AuntMinnie.comRelated Reading: ASTRO commends payment freeze for radiation treatment ASTRO chair set to testify on Medicare payment reform ASTRO: Short radiation course safe for breast cancer ASTRO: Breast radiation 'less scary' than expected ASTRO awards $275K to researchers (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 12, 2018 Category: Radiology Source Type: news

Experts uncover 110 new genes that raise the risk of breast cancer
Institute of Cancer Research in London researchers, who were heavily involved in the BRCA discovery, hope the new findings will provide a huge range of new targets for drug development. (Source: the Mail online | Health)
Source: the Mail online | Health - March 12, 2018 Category: Consumer Health News Source Type: news

Cutting Chemo Heart Risks for Breast Cancer Patients
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 12, 2018 Category: Cancer & Oncology Tags: Cardiology, Oncology, Pharmacy, News, Source Type: news

Breast cancer breakthrough: New drug can fight off deadly disease
A NEW life-saving drug has been developed to help fight the most aggressive form of breast cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - March 12, 2018 Category: Consumer Health News Source Type: news

Breast cancer breakthrough: New drug to fight off deadliest form of disease
A NEW life-saving drug has been developed to help fight the most aggressive form of breast cancer. (Source: Daily Express - Health)
Source: Daily Express - Health - March 12, 2018 Category: Consumer Health News Source Type: news

Cutting Chemo Heart Risks for Breast Cancer Patients
MONDAY, March 12, 2018 -- Two classes of blood pressure drugs show promise in preventing heart complications caused by chemotherapy for breast cancer, researchers report. One in four women who receives the chemo drug Herceptin develops potentially... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 12, 2018 Category: General Medicine Source Type: news

New treatment for aggressive breast cancer
(Lund University) Approximately 10-15 percent of breast cancer cases do not respond to treatment with hormone therapy, which means that they are more aggressive and often recur. An international research team led by researchers at Lund University in Sweden has uncovered a way to treat these aggressive tumors through manipulation of the connective tissue cells of the tumor. The researchers are now developing a new drug that transforms aggressive breast cancer so that it becomes responsive to standard hormone therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 12, 2018 Category: Cancer & Oncology Source Type: news